IGC PHARMA, INC. Cash and Cash Equivalents, Period Increase (Decrease)
IGC PHARMA, INC. (IGC) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$9.06 million for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-08-09
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$9.06M.
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$1.42M.
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $20.63M, a 1785.28% increase year-over-year.
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $5.39M, a 2043.04% increase year-over-year.
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was $23.95M, a 2038.57% increase from fiscal 2018.
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $1.12M.
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$952.66K, a 243.00% decline from fiscal 2016.
- IGC PHARMA, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $666.20K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$9.06M 10-Q · filed 2019-08-09 | -$10.48M derived: sum of 2 quarters · filed 2019-08-09 | $10.15M derived: sum of 3 quarters · filed 2019-08-09 | $15.53M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2019-03-31 | -$1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-14 | $19.20M derived: sum of 2 quarters · filed 2019-06-14 | $24.59M derived: sum of 3 quarters · filed 2019-06-14 | $23.95M 10-K · filed 2019-06-14 | ||||
| 2018-12-31 | $20.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | $26.01M derived: sum of 2 quarters · filed 2019-02-12 | $25.38M 10-Q · filed 2019-02-12 | $25.34M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-09-30 | $5.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-16 | $4.75M 10-Q · filed 2018-10-16 | $4.72M derived: sum of 3 quarters · filed 2019-08-09 | $5.81M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-06-30 | -$638.00K 10-Q · filed 2019-08-09 | -$637.64K 10-Q · filed 2018-08-03 | -$671.00K derived: sum of 2 quarters · filed 2019-08-09 | $423.00K derived: sum of 3 quarters · filed 2019-08-09 | $674.42K derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-14 | $1.06M derived: sum of 2 quarters · filed 2019-06-14 | $1.31M derived: sum of 3 quarters · filed 2019-06-14 | $1.12M 10-K · filed 2019-06-14 | $1.12M 10-K · filed 2018-06-21 | |||
| 2017-12-31 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-12 | $1.35M derived: sum of 2 quarters · filed 2019-02-12 | $1.15M 10-Q · filed 2019-02-12 | $1.15M 10-Q · filed 2018-02-20 | $946.97K derived: sum of 4 quarters · filed 2019-02-12 | |||
| 2017-09-30 | $251.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-10-16 | $59.00K 10-Q · filed 2018-10-16 | $59.00K 10-Q · filed 2017-11-17 | -$147.03K derived: sum of 3 quarters · filed 2018-10-16 | -$342.26K derived: sum of 4 quarters · filed 2018-10-16 | |||
| 2017-06-30 | -$192.42K 10-Q · filed 2018-08-03 | -$398.44K derived: sum of 2 quarters · filed 2018-08-03 | -$593.67K derived: sum of 3 quarters · filed 2018-08-03 | -$979.94K derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | -$206.03K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-21 | -$401.26K derived: sum of 2 quarters · filed 2018-06-21 | -$787.52K derived: sum of 3 quarters · filed 2018-06-21 | -$952.66K 10-K · filed 2018-06-21 | ||||
| 2016-12-31 | -$195.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-20 | -$581.50K derived: sum of 2 quarters · filed 2018-02-20 | -$746.64K 10-Q · filed 2018-02-20 | -$747.00K 10-Q · filed 2017-02-21 | $135.56K derived: sum of 4 quarters · filed 2018-02-20 | |||
| 2016-09-30 | -$386.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-17 | -$551.41K 10-Q · filed 2017-11-17 | $330.79K derived: sum of 3 quarters · filed 2017-11-17 | $301.36K derived: sum of 4 quarters · filed 2017-11-17 | ||||
| 2016-06-30 | -$165.14K 10-Q · filed 2017-08-18 | $717.06K derived: sum of 2 quarters · filed 2017-08-18 | $687.63K derived: sum of 3 quarters · filed 2017-08-18 | $665.95K derived: sum of 4 quarters · filed 2017-08-18 | ||||
| 2016-03-31 | $882.20K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-14 | $852.77K derived: sum of 2 quarters · filed 2017-07-14 | $831.10K derived: sum of 3 quarters · filed 2017-07-14 | $666.20K 10-K · filed 2017-07-14 | ||||
| 2015-12-31 | -$29.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-21 | -$51.10K derived: sum of 2 quarters · filed 2017-02-21 | -$216.00K 10-Q · filed 2017-02-21 | -$216.86K 10-Q · filed 2016-02-16 | -$509.52K derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-09-30 | -$21.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-21 | -$186.57K 10-Q · filed 2016-11-21 | -$480.09K derived: sum of 3 quarters · filed 2016-11-21 | -$707.88K derived: sum of 4 quarters · filed 2016-11-21 | ||||
| 2015-06-30 | -$164.90K 10-Q · filed 2016-08-16 | -$458.42K derived: sum of 2 quarters · filed 2016-08-16 | -$686.21K derived: sum of 3 quarters · filed 2016-08-16 | -$2.29M derived: sum of 4 quarters · filed 2016-08-16 | ||||
| 2015-03-31 | -$293.52K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-14 | -$521.31K derived: sum of 2 quarters · filed 2016-07-14 | -$2.13M derived: sum of 3 quarters · filed 2016-07-14 | -$202.07K 10-K · filed 2016-07-14 | ||||
| 2014-12-31 | -$227.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | -$1.83M derived: sum of 2 quarters · filed 2016-02-16 | $91.45K 10-Q · filed 2016-02-16 | $677.39K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-09-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-13 | $319.24K 10-Q · filed 2015-11-13 | $905.18K derived: sum of 3 quarters · filed 2015-11-13 | $619.03K derived: sum of 4 quarters · filed 2015-11-13 | ||||
| 2014-06-30 | $1.93M 10-Q · filed 2015-08-14 | $2.51M derived: sum of 2 quarters · filed 2015-08-14 | $2.23M derived: sum of 3 quarters · filed 2015-08-14 | $2.30M derived: sum of 4 quarters · filed 2015-08-14 | ||||
| 2014-03-31 | $585.94K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-14 | $299.80K derived: sum of 2 quarters · filed 2015-07-14 | $375.10K derived: sum of 3 quarters · filed 2015-07-14 | -$37.86K 10-K · filed 2015-07-14 | ||||
| 2013-12-31 | -$286.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-12 | -$210.84K derived: sum of 2 quarters · filed 2015-02-12 | -$623.79K 10-Q · filed 2015-02-12 | -$1.67M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-09-30 | $75.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | -$337.65K 10-Q · filed 2014-11-13 | -$1.38M derived: sum of 3 quarters · filed 2014-11-13 | $115.47K derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2013-06-30 | -$412.96K 10-Q · filed 2014-08-14 | -$1.46M derived: sum of 2 quarters · filed 2014-08-14 | $40.17K derived: sum of 3 quarters · filed 2014-08-14 | -$67.97K derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $453.12K derived: sum of 2 quarters · filed 2014-07-15 | $344.98K derived: sum of 3 quarters · filed 2014-07-15 | $501.47K 10-K · filed 2014-07-15 | ||||
| 2012-12-31 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | $1.39M derived: sum of 2 quarters · filed 2014-02-14 | $1.55M 10-Q · filed 2014-02-14 | -$2.34M derived: sum of 4 quarters · filed 2014-07-15 | ||||
| 2012-09-30 | -$108.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | $48.35K 10-Q · filed 2013-11-08 | -$3.83M derived: sum of 3 quarters · filed 2014-07-15 | -$155.53K derived: sum of 4 quarters · filed 2014-07-15 | ||||
| 2012-06-30 | $156.49K 10-Q · filed 2013-08-16 | -$3.73M derived: sum of 2 quarters · filed 2014-07-15 | -$47.39K derived: sum of 3 quarters · filed 2014-07-15 | -$458.01K derived: sum of 4 quarters · filed 2014-07-15 | ||||
| 2012-03-31 | -$3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | -$203.88K derived: sum of 2 quarters · filed 2014-07-15 | -$614.50K derived: sum of 3 quarters · filed 2014-07-15 | -$1.02M 10-K · filed 2014-07-15 | -$1.02M 10-K · filed 2012-07-16 | |||
| 2011-12-31 | $3.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-13 | $3.27M derived: sum of 2 quarters · filed 2013-02-13 | $2.86M 10-Q · filed 2013-02-13 | $2.97M derived: sum of 4 quarters · filed 2013-02-13 | ||||
| 2011-09-30 | -$410.62K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-14 | -$816.46K 10-Q · filed 2012-11-14 | -$703.36K derived: sum of 3 quarters · filed 2012-11-14 | $378.65K derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | -$405.83K 10-Q/A · filed 2012-08-21 | -$292.74K derived: sum of 2 quarters · filed 2012-08-21 | $789.27K derived: sum of 3 quarters · filed 2012-08-21 | $575.20K derived: sum of 4 quarters · filed 2012-08-21 | ||||
| 2011-03-31 | $113.09K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-16 | $1.20M derived: sum of 2 quarters · filed 2012-07-16 | $981.03K derived: sum of 3 quarters · filed 2012-07-16 | $740.36K 10-K · filed 2012-07-16 | ||||
| 2010-12-31 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-16 | $867.93K derived: sum of 2 quarters · filed 2012-02-16 | $627.27K 10-Q · filed 2012-02-16 | |||||
| 2010-09-30 | -$214.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-18 | -$454.75K 10-Q · filed 2011-11-18 | ||||||
| 2010-06-30 | -$240.67K 10-Q · filed 2011-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |